Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.
about
Management of Membranous Nephropathy in AsiaMembranous nephropathy: not just a disease for adultsAn adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomyA case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.Smoking is a risk factor for the progression of idiopathic membranous nephropathy.Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London.Controversies in the treatment of idiopathic membranous nephropathy.Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trialImmunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adultsAssessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstructionThe natural history of the non-nephrotic membranous nephropathy patient.A case of podocytic infolding glomerulopathy with multiple myeloma.Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathyComparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort studyPrevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.Microscopic Haematuria and Clinical Outcomes in Patients With Stage 3-5 Nondiabetic Chronic Kidney Disease.Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point.Treatment pattern in patients with idiopathic membranous nephropathy-practices in Sweden at the start of the millenniumStepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathyPatients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational StudyImmunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations.Management of idiopathic membranous nephropathy.Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy.Partial remission by cyclosporine monotherapy in a patient with membranous nephropathy superimposed diabetic nephropathy.Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria).Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.Membranous nephropathy associated with pregnancy: an anti-phospholipase A2 receptor antibody-positive case report.The clinicopathological features of patients with membranous nephropathy.Diffusion-weighted imaging and pathology of chronic kidney disease: initial study.Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan.Long-term outcomes of initial therapy for idiopathic membranous nephropathy.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
P2860
Q26740481-B8F7692B-76DE-445F-8C10-D94F75B3235AQ26866206-9BBD21BF-195A-452F-A0C8-53A8D30BDB60Q33622282-72C01FCA-CA73-408F-9331-CFF4BCCA2D41Q33628246-B17A8629-ACE1-4CE3-9E72-62D89BDC126BQ33806897-A69E6DA2-C55E-42C2-9546-7FD8DF6200C3Q33823525-3A94893E-2665-4B3F-948F-0F4BC1739011Q34248343-6B57CFB9-C4BA-448C-AE2E-8236F0751032Q34324240-B34C9F5C-94BD-4A1A-996F-9D71A40F9B35Q34408113-265F33EA-38D7-4911-9FA7-94840ECE00E0Q34436358-4C46C3BF-800B-4172-AA0A-3A49B0CFC78DQ34658973-5FF97445-0FCF-4F03-84B5-D2333A1386C5Q35094397-C892C085-09BF-4000-B926-72FBA8A500DBQ35433416-E3A80113-A03D-4078-9D3D-B22934F545E8Q35861417-F4B4DBB3-C93B-49CB-BD1C-1081FD320CF7Q35977341-CCDFF057-01D5-4D44-9B19-A2BC0DBF74C7Q36168260-318C8AE8-7F6D-4663-AF5A-88D2CAE1D136Q36265388-875CD18B-CCD1-4410-987D-6623D091E2D5Q36524378-51F17C01-4770-44AB-85C2-7A3655C9EAA5Q36689205-DF978270-0B37-4A3D-93A1-A272010E83E7Q36872799-61D0E951-4584-4654-B09A-6CA196B0B14DQ36992978-A43E5297-1D77-4D85-888A-8D8A8954F36AQ37695117-152909A9-32DB-4D76-BB4D-674F59B98F9CQ37779802-F147A3A2-1CA7-48D0-AA1F-1AD281A75229Q39127541-A885F9AF-ECA6-46CC-9C20-B199F52ACD04Q41073990-C3D758C2-8E17-46CF-ABDD-4A8A909BEA0CQ41428318-9E58C4CE-16AD-41C6-A61E-F5404A34C197Q41709119-5967B2D3-1F66-40D0-B8FC-8AC3A11F4D97Q41854722-A335536F-DF60-4F05-BA1D-6DE8A28B83F2Q42290044-2ECFAD76-1EA0-44A2-AA75-E00485A7F6B6Q44366494-1D1727B8-99C4-4EBF-8CEA-3ACEC02357AFQ44420378-9A1184DD-1988-42A1-8B27-5980707A9C56Q44717786-4EAFB445-852F-4471-9879-E26BA9D09ABCQ47168526-9EB0CD46-93BE-47EB-A836-FA7275C97932Q47551400-2C9BD4F9-722F-4456-AF5C-72F4D518AF5EQ49220788-2A2548B9-31DF-47A9-92D2-F327B4FC09E6Q50129903-DB727931-FF52-429E-BCC6-2380A97FDB3CQ50932968-396CB7D3-9687-411D-B876-C2F9FBC1778FQ51045833-10ED024A-36B8-4902-805C-73BE09AB5E33Q51246368-E8623245-AA05-41B8-A2C1-92564C2AA604Q52670774-23A59E20-F254-4064-8121-FE1D8C0F5771
P2860
Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@ast
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@en
type
label
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@ast
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@en
prefLabel
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@ast
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@en
P2093
P1433
P1476
Prognosis and risk factors for ...... h nephrotic syndrome in Japan.
@en
P2093
Ashio Yoshimura
Hideo Shiiki
Hideto Sakai
Hitoshi Yokoyama
Kiyoshi Kurokawa
Noriaki Yorioka
Research Group on Progressive Renal Diseases in Japan
Shinichi Nishi
Takao Saito
Tetsuya Mitarai
P304
P356
10.1111/J.1523-1755.2004.00518.X
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1052540664